Rule
This market resolves YES if a major supplement industry trade publication (Natural Products Insider, Nutrition Business Journal, INSIDER, or Nutritional Outlook) reports that Nicotinamide Riboside (NR) was the top-selling longevity-positioned single-ingredient supplement by US retail dollar sales for calendar year 2026, published by March 31, 2027. If no such report is published by the deadline, or if another supplement is reported as the top seller, this market resolves NO.
Source: https://www.spins.com/
Resolves by Apr 28, 2027.
13 comments
historically the longevity category gets hijacked by whatever gets celebrity-backed first, and NR hasn't landed that yet at 32, that's my fade.
nr has the hype but not the repeat.
nr's not winning on brand love alone, but the cpg playbook in that video shows how a single ingredient becomes foodinstitute.com/video/fi-spotlight-top-insights-from-th…
nr's got the clinical story that actually sticks with retail buyers
nr's got the science momentum and the money backing it
nr's got the biotech credibility but lacks the founder conviction that moves retail